[1] Burzykowski T, Molenberghs G, Abeck D, et al. High prevalence of foot diseases in Europe:results of the Achilles Project[J]. Mycoses, 2003,46(11-12):496-505.
[2] Ilkit M, Durdu M. Tinea pedis:the etiology and global epidemiology of a common fungal infection[J].Crit Rev Microbiol. 2015;41(3):374-388.
[3] Ameen M. Epidemiology of superficial fungal infections[J]. Clinics in Dermatology, 2010,28(2):197-201.
[4] Havlickova B, Czaika VA, Friedrich M.Epidemiological trends in skin mycoses worldwide[J]. Mycoses, 2008,51(Suppl 4):2-15.
[5] 杨利红,赵颖,严淑贤,等.上海新泾社区50岁以上居民足癣患病情况调查[J].中国真菌学杂志,2012,7(2):92-94.
[6] Watanabe S, Harada T, Hiruma M, et al. Epidemiological survey of foot diseases in Japan:results of 30,000 foot checks by dermatologists[J]. J Dermatol, 2010,37(5):397-406.
[7] Cheng S, Chong L.A prospective epidemiological study on tinea pedis and onychomycosis in Hong Kong[J]. Chin Med J (Engl), 2002,115(6):860-865.
[8] 费实,肖常青,李振洁,等.1999~2007年皮肤科门诊浅部真菌发病及镜检情况分析[J]. 中国真菌学杂志,2009,4(2):93-96,101.
[9] 王爱平,高露娟,席丽艳,等. 足癣患者治疗现状调查[J].中国真菌学杂志, 2014, 9(6):335-338.
[10] 徐楠,温海.足癣复发对患者生活质量的影响[J].中国真菌学杂志,2006,l(3):174-176.
[11] Daniel CR III, Gupta AK,Daniel MP,et al. Two feet-one hand syndrome:a retrospective multicenter survey[J]. Int J Dermatol,1997,36(9):658-660.
[12] Wilson M, Bender S, Lynfield Y, Finelli LJ. Two feet-one hand syndrome[J]. J Am Podiatr Med Assoc,1988,78(5):250-253.
[13] Park BC, Lee SJ, Kim DW, et al. Molecular identification of mycologic correlation inpatients with concomitant tinea pedis and tinea manuum infection[J]. Arch Dermatol, 2009,145(2):205-207.
[14] Müller DP, Hoffmann R, Welzel J. Microorganisms of the toe web and their importance for erysipelas of the leg[J]. J Dtsch Dermatol Ges, 2014,12(8):691-695.
[15] Roldan YB, Mata-Essayag S, Hartung C. Erysipelas and tinea pedis[J]. Mycoses, 2000,43(5):181-183.
[16] Pavlotsky F, Amrani S, Trau H. Recurrent erysipelas:risk factors[J]. J Dtsch Dermatol Ges, 2004, 2(2):89-95.
[17] Cannon J, Rajakaruna G, Dyer J,et al.Severe lower limb cellulitis:defining the epidemiology and risk factors for primary episodes in a population-based case-control study[J]. Clin Microbiol Infect, 2018, 24(10):1089-1094.
[18] Romano C, Rubegni P, Ghilardi A,et al. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum[J]. Mycoses, 2006,49(3):249-250.
[19] Kaaman T,Torssander J. Dermatophytid-a misdiagnosed entity[J]? Acta Derm Venereol, 1983,63(5):404-408.
[20] 李春阳,李诚菊,徐永豪,等. 2%酮康唑乳膏治疗浅部真菌病开放性、随机对照临床研究[J]. 中国真菌学杂志, 2011,6(2):112-114.
[21] 王美芳,李邻峰,程海燕,等.1%硝酸硫康唑喷雾剂治疗足癣及鞋袜用药对预防复发的作用[J]. 中国真菌学杂志, 2018,13(3):164-167.
[22] 王爱平,温海,赖维,等. 1%联苯苄唑霜治疗足癣长期疗效观察[J]. 中国真菌学杂志, 2008,3(4):224-227.
[23] 符美华,李岷,李若瑜,等.不同疗程1%卢立康唑乳膏治疗足癣的多中心、随机双盲对照研究[J].中华皮肤科杂志,2014,47(7):453-456.
[24] Jarratt M, Jones T, Adelglass J, et al. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥ 12 years of age with interdigital tinea pedis:a phase 3, randomized, double-blind,vehicle-controlled study[J]. J Drugs Dermatol, 2014,13(7):838-846.
[25] Korting HC, Kiencke P, Nelles S,et al. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen:results of a meta-analysis[J]. Am J Clin Dermatol, 2007,8(6):357-364.
[26] 李岷,顾军,毕志刚,等.1%盐酸布替萘芬乳膏治疗体股癣、足癣疗效观察[J].临床皮肤科杂志,2006, 35(7):471-472.
[27] Gupta AK. Butenafine:an update of its use in superficial mycoses[J]. Skin Therapy Lett, 2002,7(7):1,2, 5.
[28] Stein Gold LF, Parish LC, Vlahovic T, et L. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis:pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials[J]. J Drugs Dermatol, 2013,12(8):911-918.
[29] 王爱平,余进,陈伟,等. 0.25%盐酸阿莫罗芬霜治疗足癣疗效和安全性评价[J].中国真菌学杂志,2007,2(5):293-295.
[30] 王爱平,王端礼,虞瑞尧,等.1%环吡酮胺软膏治疗皮肤真菌病疗效观察[J].中华皮肤科杂志, 1998,31(5):337
[31] Aly R, Fisher G, Katz I, et al. Ciclopirox gel in the treatment of patients with interdigital tinea pedis[J]. Int J Dermatol, 2003, 42(Suppl 1):29-35.
[32] 王英,沈永年,朱红梅,等.利拉萘酯乳膏治疗体股癣及足癣的多中心随机双肓对照观察[J]. 中华皮肤科杂志,2007,40(8):476-478.
[33] 吴建华,温海,陶苏江,等. 萘替芬酮康唑乳膏治疗足癣209例[J]. 中国新药与临床杂志,2006,25(5):328-331.
[34] Patel VM, Schwartz RA, Lambert WC. Topical antiviral and antifungal medications in pregnancy:a review of safety profiles[J]. J Eur Acad Dermatol Venereol,2017,31(9):1440-1446.
[35] 中国体癣和股癣诊疗指南工作组.中国体癣和股癣诊疗指南(2018修订版)[J].中国真菌学杂志,2019,14(1):1-3.
[36] Gupta AK, Foley KA, Versteeg SG. New antifungal agents and new formulations against dermatophytes[J]. Mycopathologia, 2017,182(1-2):127-141.
[37] Tsunemi Y.Oral antifungal drugs in the treatment of dermatomycosis[J]. Med Mycol J, 2016,57(2):J71-75. |
